NASDAQ:BSGM - BioSig Technologies Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00 %
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$0.70
▲ +0.04 (6.06%)

This chart shows the closing price for BSGM by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New BioSig Technologies Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for BSGM and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for BSGM

Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for BioSig Technologies in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $0.00. The average price target represents a -100.00% upside from the last price of $0.70.

This chart shows the closing price for BSGM for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is N/A

The current consensus among 0 polled investment analysts is to n/a stock in BioSig Technologies. This rating has held steady since March 2021, when it changed from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/10/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/10/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/9/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
10/7/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
1/5/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/5/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/4/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
7/4/2022

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
3/30/2020Roth CapitalInitiated CoverageBuy$9.00Low
2/20/2019LaidlawSet Price TargetBuy$11.00Medium
12/6/2018Roth CapitalReiterated RatingBuyLow
12/6/2018Roth CapitalInitiated CoverageBuy$14.00 ➝ $14.00Low
10/1/2017Chardan CapitalReiterated RatingBuyN/A
(Data available from 7/5/2017 forward)

News Sentiment Rating

0.78 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 4 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
12/6/2021
  • 4 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
1/5/2022
  • 3 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
2/4/2022
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
3/6/2022
  • 1 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
4/5/2022
  • 1 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/5/2022
  • 1 very positive mentions
  • 1 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
6/4/2022
  • 2 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
7/4/2022

Current Sentiment

  • 2 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
BioSig Technologies logo
BioSig Technologies, Inc., together with its subsidiaries, operates as medical device company. The company's proprietary product includes precise uninterrupted real-time evaluation of electrograms electrophysiology (PURE EP) system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time. It also focuses on enhancing intracardiac signal acquisition and diagnostic information for the procedures of atrial fibrillation, as well as is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures. The company has a research agreement with University of Minnesota to develop novel therapies to treat sympathetic nervous system diseases; and a strategic collaboration with the Mayo Foundation for Medical Education and Research to develop an AI-and machine learning software solution for PURE EP systems. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut.
Read More

Today's Range

Now: $0.70
Low: $0.65
High: $0.74

50 Day Range

MA: $0.90
Low: $0.63
High: $1.22

52 Week Range

Now: $0.70
Low: $0.55
High: $4.44

Volume

12,638 shs

Average Volume

243,039 shs

Market Capitalization

$27.73 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.8

Frequently Asked Questions

What sell-side analysts currently cover shares of BioSig Technologies?

The following sell-side analysts have issued research reports on BioSig Technologies in the last year:
View the latest analyst ratings for BSGM.

What is the current price target for BioSig Technologies?

0 Wall Street analysts have set twelve-month price targets for BioSig Technologies in the last year.
View the latest price targets for BSGM.

What is the current consensus analyst rating for BioSig Technologies?

BioSig Technologies currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for BSGM.

How do I contact BioSig Technologies' investor relations team?

BioSig Technologies' physical mailing address is 54 WILTON ROAD, WESTPORT CT, 06880. The company's listed phone number is (230) 409-5444 and its investor relations email address is [email protected] The official website for BioSig Technologies is www.biosig.com. Learn More about contacing BioSig Technologies investor relations.